Delivery Order SPE2DR25D3103-SPE2DR26F9F17
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,453.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,556.63 for Carvedilol ER 40 mg capsules (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,146.89 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, reflecting the expedited nature of military pharmaceutical procurement. The contract was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $4,905.66 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of May 13, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with a firm fixed price ceiling value of $9,931.33 and an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency awarded a $1,353.29 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction executed under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $9,305.50. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F17Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) under a non-competitive, non-set-aside contract. The award, valued at $3,994.69, was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The carvedilol delivery falls within the company's extensive portfolio of pharmaceutical products supplied to federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/13/25 |